A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803
Clinical trial NCT05286281 · COMPLETED
Trial details
- NCT number
- NCT05286281
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2022-05-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.